Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Allergan plc

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
U.S. FDA Approves JUVEDERM® ULTRA XC for Use in Lips
First and Only Filler Approved for Lip Augmentation that Lasts Up to One Year 
Tickers AGN
From PR Newswire
Allergan Announces Updated Second-Half 2015 Continuing Operations Financial Forecast
-- Continued Strong Execution Positions Company for Continued Growth in 2015 and Expanded Growth in 2016 and Beyond -- 
Tickers AGN
From PR Newswire
Allergan Launches Generic Version of INVEGA® (paliperidone)
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA® (paliperidone extended-release tablets) in the U.S.... 
Tickers AGN
From PR Newswire
Allergan Supports World Alzheimer's Disease Day by Giving Back
Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced a nationwide partnership with the Caregiver Action Network (CAN), the nation's leading family caregiver organization,... 
Tickers AGN
From PR Newswire
Allergan Confirms Generic Rytary® Patent Challenge
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking... 
Tickers AGN
From PR Newswire
Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR™ (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults
- The safety and efficacy of oral, once-daily VRAYLAR was established in a clinical trial program involving more than 2,700 patients - 
Tickers AGN
From PR Newswire
Allergan Partners with U.S. Women's Health Alliance Increasing Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
-- Agreement will make LILETTA® Available to Women Across USWHA Health Care Groups Nationwide -- 
Tickers AGN
From PR Newswire
Allergan Anti-Infective Portfolio Highlighted in 24 Abstracts at ICAAC 2015
Allergan plc (NYSE: AGN) today announced that its infectious disease portfolio will be featured in 24 abstracts highlighting new data at the Interscience Conference on Antimicrobial Agents and... 
Tickers AGN AZN
From PR Newswire
Allergan And Perrigo Receive FDA Approval Of Three Extended Release Products Equivalent To Mucinex® And Mucinex® DM
Allergan plc (NYSE: AGN) and its partner Perrigo Company plc (NYSE: PRGO; TASE) announced today that Allergan has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug... 
Tickers AGN PRGO
From PR Newswire
Allergan Expands Access to IUDs for Millions of Underserved Women in the US by Announcing Agreement with Apexus for Nationwide Distribution of LILETTA® (levonorgestrel-releasing intrauterine system) 5
Allergan plc, a leading global pharmaceutical company, has announced an agreement to make LILETTA® available to the safety-net provider locations that Apexus, the 340B Drug Pricing Program Prime Vendor... 
Tickers AGN
From PR Newswire
Allergan Announces Agreement with Amneal Related to NAMENDA XR® Patent Litigation
Allergan plc (NYSE: AGN), today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into a settlement... 
Tickers AGN
From PR Newswire
Allergan to Present at Morgan Stanley Global Healthcare Conference 2015
Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that Brent Saunders, CEO and President of Allergan, will provide an overview and update of the Company's business at... 
Tickers AGN
From PR Newswire
Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering
- Acquisition Adds Global Rights to XEN45, a Minimally Invasive Best-In-Class Implantable Shunt for Glaucoma -- 
Tickers AGN
From PR Newswire
Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
- Label now includes new data on patients with ABSSSI with baseline Staphylococcus aureus bacteremia and supports shorter intravenous (IV) infusion time for TEFLARO - 
Tickers AGN AZN
From PR Newswire
Positive Phase III Results Demonstrate Efficacy Of Antibiotic Medicine AVYCAZ™ (ceftazidime-avibactam) In Complicated Urinary Tract Infections
NYSE: AGN) Allergan plc. today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ™ (ceftazidime-avibactam) as a treatment for... 
Tickers AGN
From PR Newswire
Allergan Successfully Completes Naurex Acquisition
- Two Lead Development Products Rapastinel (GLYX-13) and NRX-1074 Demonstrated Rapid Onset of Action and Robust Efficacy in Phase 2 Studies in Major Depressive Disorder - 
Tickers AGN
From PR Newswire
Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (sulfacetamide sodium
From PR Newswire
U.S. FDA Accepts BOTOX® (onabotulinumtoxinA) Resubmission for the Treatment of Lower Limb Spasticity in Adults
Tickers AGN
From PR Newswire
Allergan Confirms Generic Noxafil® Patent Challenge
Tickers AGN
From PR Newswire
Allergan Successfully Completes Oculeve Acquisition
-- Enhances Allergan's World-Class Position in Dry Eye Care -- 
Tickers AGN
From PR Newswire
Allergan Reports Exceptional Second Quarter 2015 Performance with 116% Increase in Net Revenue to $5.76 Billion and 29% Growth in Non-GAAP EPS to $4.41
-- Adjusted EBITDA Increases 203% to $2.6 Billion in Second Quarter 2015 -- 
Tickers ACT AGN
From PR Newswire
FDA Approves 28 Additional Styles Of Allergan's Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Tickers AGN
From PR Newswire
Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration
Tickers AGN KYTH
From PR Newswire
Allergan Confirms Generic Tyvaso® Patent Challenge
Tickers AGN
From PR Newswire
Allergan Kicks off REFRESH AMERICA Program to Supply First Responders With Free Eye Drops
Allergan partners with U.S. First Responders Association to support America's Heroes with In-Kind Donation of REFRESH Products through July 2016 
From PR Newswire
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
Tickers AGN KYTH
From PR Newswire
Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion
- Bold Action to Reload Capital Structure Positions Allergan to Build on Track Record of Value Creation - 
Tickers AGN
From PR Newswire
Allergan to Acquire Naurex
- Builds on Allergan's World-Class Position and Leadership Strategy in Mental Health - 
Tickers AGN
From PR Newswire
Allergan Launches Bold Campaign For Millennial Women
Leading Growth Pharma And Women's Healthcare Company Introduces #ActuallySheCan Campaign To Celebrate A Generation Of Women 
From PR Newswire
Allergan to Highlight Data from Its Alzheimer's Disease Portfolio at the 2015 Alzheimer's Association International Conference (AAIC)
Tickers AGN
From PR Newswire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.